Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

INFUSION AND STERILE PREPARATIONS
INFUSION AND STERILE PREPARATIONS Permanent storage and easy retrieval of Journal articles and formulations.
Only $95 per CD
  • Print Journal articles in color from the pdf file for your marketing needs.
  • Eliminate long searches through past issues for articles and formulations.

This CD contains the following articles listed by volume, issue and page number:

INFUSION RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Vol. 19 No. 6 521
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Vol. 19 No. 5 432
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Vol. 19 No. 4 334
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Vol. 18 No. 4 313
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Vol. 15 No. 6 504
Home Infusion: Overview of the Infusion Patient-Care Process Vol. 15 No. 4 270
Stability of Ertapenem in an Elastomeric Infusion Device Vol. 15 No. 3 252
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Vol. 15 No. 3 259
Home Infusion: Available Vascular Access Devices and Common Therapies Vol. 15 No. 3 183
Home Infusion Basics for the Non-Infusion Pharmacist Vol. 15 No. 2 94
Home Infusion Accreditation: Another Quality Recognition Branding Tool Vol. 14 No. 5 360
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device Vol. 14 No. 5 436
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Vol. 12 No. 2 170
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Vol. 8 No. 2 136
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 4 310
Phenytoin Injections: From Compounding to Cerebyx Vol. 6 No. 6 410
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Vol. 6 No. 6 428
Total Parenteral Nutrition for Animals Vol. 6 No. 5 328
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Vol. 6 No. 2 120
Creating a Productivity Measurement Tool for a Home Infusion Pharmacy Vol. 6 No. 1 24
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Vol. 6 No. 1 55
Ceftazidime 20-mg/mL for Ambulatory Infusion Pump Vol. 5 No. 6 451
New Perspectives on Vancomycin Use in Home Care, Part 1 Vol. 5 No. 6 465
Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 5 No. 5 394
Assessment of the Stability of Teicoplanin in Intravenous Infusions Vol. 5 No. 5 397
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor Vol. 5 No. 4 328
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Vol. 5 No. 1 69
Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 73
Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 5 No. 1 75
Disposable Ambulatory Infusion Devices: A Review - Part 3 Vol. 4 No .6 442
Ambulatory Syringe Infusion Devices: A Review - Part 2 Vol. 4 No. 5 364
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review Vol. 4 No. 4 281
Needleless Infusion Systems Vol. 4 No. 3 183
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration Vol. 4 No. 2 150
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Vol. 4 No. 1 66
Electronically Controlled Drug Delivery Vol. 3 No. 6 439
Compounding Radiolabeled Blood Cells for Diagnostic Imaging Vol. 3 No. 6 443
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Vol. 3 No. 5 412
Catheter Occlusion: Causes and Solutions Vol. 2 No. 5 342
TPN Bulk Compounding from Bulk Drug Substances Vol. 2 No. 5 347
The Feasibility and Benefits of TPN in Horses: A Review of the Findings Vol. 2 No. 5 351
Model Parenteral Nutrition Formulation (Veterinary) Vol. 2 No. 5 352
Required Documentation for Home Infusion Pharmacies - Compounding Records Vol. 2 No. 5 354
Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids Vol. 2 No. 5 366
Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids Vol. 2 No. 5 367
Three-in-One Adult Total Parenteral Nutrition Vol. 2 No. 5 371
Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Vol. 2 No. 5 382
Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions Vol. 2 No. 5 385
Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps Vol. 1 No. 6 430
Home Infusion and Alternative-Site Health Care: The Big Picture Vol. 1 No. 5 294
Continued Growth Predicted for Home Infusion Market Vol. 1 No. 5 298
Drug Stability and Compatibility: Special Considerations for Home Health Care Vol. 1 No. 5 301
Ambulatory Infusion Pump Review Vol. 1 No. 5 306
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures Vol. 1 No. 1 54

STERILE PREPARATIONS RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Vol. 19 No. 6 491
Cefepime Hydrochloride 100-mg/mL Injection Vol. 19 No. 6 505
Cefotaxime 100-mg/mL Injection Vol. 19 No. 6 506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Vol. 19 No. 6 507
Estradiol Valerate 40-mg/mL in Oil Injection Vol. 19 No. 6 509
Levetiracetam 100-mg/mL Injection (Concentrate) Vol. 19 No. 6 510
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Vol. 19 No. 5 383
Sterile Filtration Vol. 19 No. 5 393
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Vol. 19 No. 4 268
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Vol. 19 No. 4 315
Ammonium Molybdate 25-mcg/mL Injection Vol. 19 No. 4 324
Cytarabine 50-mg/mL Injection Vol. 19 No. 4 328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Vol. 19 No. 4 329
Oxytocin 10-units/mL Injection Vol. 19 No. 4 330
Phytonadione 2-mg/mL Injection Vol. 19 No. 4 331
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Vol. 19 No. 3 182
Quality Assurance and Quality Control, Part 2 Vol. 19 No. 3 215
Basics of Sterile Compounding: Contamination Control Vol. 19 No. 3 232
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 3 246
Scopolamine Hydrobromide -.4-mg/mL Injection Vol. 19 No. 3 247
Protocol of Blood Serum Eye Drops Vol. 19 No. 3 252
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Vol. 19 No. 3 261
New England Compounding Center Indictment Vol. 19 No. 2 94
Quality Assurance and Quality Control, Part 1 Vol. 19 No. 2 121
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Vol. 19 No. 2 127
Aminohippurate Sodium 200-mg/mL Injection Vol. 19 No. 2 143
L-Cysteine Hydrochloride 50-mg/mL Injection Vol. 19 No. 2 146
Morrhuate Sodium 5% Injection Vol. 19 No. 2 147
Pancuronium Bromide 1-mg/mL Injection Vol. 19 No. 2 149
Physostigmine Salicylate 1-mg/mL Injection Vol. 19 No. 2 150
Trypan Blue 0.06% Ophthalmic Solution Vol. 19 No. 2 151
Basics of Sterile Compounding: Aseptic Processing Vol. 19 No. 1 49
Cisplatin 1-mg/mL Injection Vol. 19 No. 1 62
Daunorubicin 5-mg/mL Injection Vol. 19 No. 1 63
Erythromycin 50-mg/mL Injection Vol. 19 No. 1 64
Hydralazine Hydrochloride 20-mg/mL Injection Vol. 19 No. 1 65
Phentolamine Mesylate 5-mg/mL Injection Vol. 19 No. 1 69
PreScription: "Named Formulas" Database Available Vol. 18 No. 6 444
Depyrogenation Options for the Compounding Cleanroom Vol. 18 No. 6 446
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Vol. 18 No. 6 479
Dexmedetomidine 100 mcg/mL Injection Vol. 18 No. 6 495
Leucovorin 10-mg/mL Injection Vol. 18 No. 6 497
Levocarnitine 200-mg/mL Injection Vol. 18 No. 6 498
Methylene Blue 10-mg/mL Injection Vol. 18 No. 6 500
Oxacillin Sodium 167-mg/mL Injection Vol. 18 No. 6 502
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Vol. 18 No. 5 358
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Vol. 18 No. 5 397
Azithromycin 100-mg/mL Injection Vol. 18 No. 5 408
Dexpanthenol 250-mg/mL Injection Vol. 18 No. 5 410
Ephedrine Sulfate 50-mg/mL Injection Vol. 18 No. 5 411
Fluorescein 100-mg/mL Injection Vol. 18 No. 5 412
Indocyanine green 2.5-mg/mL Injection Vol. 18 No. 5 413
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Vol. 18 No. 4 270
Basics of Compounding Sterile Preparations: Nomenclature and Considerations Vol. 18 No. 4 313
Atracurium Besylate 10-mg/mL Injection, Preserved Vol. 18 No. 4 322
Calcitriol 1-mcg/mL Injection Vol. 18 No. 4 324
Chloramphenicol 100-mg/mL Injection Vol. 18 No. 4 325
Indigo Carmine Injection Vol. 18 No. 4 329
Propranolol Hydrochloride 1-mg/mL Injection Vol. 18 No. 4 330
Zinc 1-mg/mL Injection Vol. 18 No. 4 331
Bupivacaine Hydrochloride 0.5% Injection Vol. 18 No. 3 234
Lidocaine Hydrochloride 1% Injection Vol. 18 No. 3 237
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Vol. 18 No. 2 94
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Vol. 18 No. 2 123
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Vol. 18 No. 2 131
Fludarabine Phosphate 25-mg/mL Injection Vol. 18 No. 2 143
Mecasermin 10-mg/mL Injection Vol. 18 No. 2 144
Methylprednisolone 40-mg/mL Injection Vol. 18 No. 2 145
Polymixin B Injection Vol. 18 No. 2 146
Rocuronium Bromide 10-mg/mL Injection Vol. 18 No. 2 147
Selenium 40-mcg/mL Injection Vol. 18 No. 2 149
Sincalide 1-mcg/mL Injection Vol. 18 No. 2 150
Testosterone Enanthate 200-mg/mL Injection Vol. 18 No. 2 151
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Vol. 18 No. 1 6
Determination of Risk for Sterile Preparations Vol. 18 No. 1 30
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Vol. 18 No. 1 46
Basics of Sterile Compounding: Bubble Point Testing Vol. 18 No. 1 54
Aztreonam Injection Vol. 18 No. 1 60
Bumetanide 0.25-mg/mL Injection Vol. 18 No. 1 61
Droperidol 2.5-mg/mL Injection Vol. 18 No. 1 62
Potassium Chloride 2-mEq/mL Injection Vol. 18 No. 1 67
Procainamide Hydrochloride 100-mg/mL Injection Vol. 18 No. 1 68
Vasopressin 20-units/mL Injection Vol. 18 No. 1 69
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Vol. 17 No. 6 465
Benztropine Mesylate 1-mg/mL Injection Vol. 17 No. 6 498
Cefazolin 250-mg/mL Injection Vol. 17 No. 6 499
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Vol. 17 No. 6 502
Dihydroergotamine Mesylate 1-mg/mL Injection Vol. 17 No. 6 503
Compounding Pharmacies: Before and After an Inspection Vol. 17 No. 5 358
Acyclovir 50-mg/mL Injection Vol. 17 No. 5 414
Aminocaproic Acid 250-mg/mL Injection Vol. 17 No. 5 415
Clindamycin 150-mg/mL Injection Vol. 17 No. 5 416
Fluorouracil 50-mg/mL Injection Vol. 17 No. 5 417
Hydroxyzine Hydrochloride 25-mg/mL Injection Vol. 17 No. 5 418
Indomethacin 1-mg/mL Injection Vol. 17 No. 5 419
Mesna 100-mg/mL Injection Vol. 17 No. 5 420
Methotrexate 25-mg/mL Injection Vol. 17 No. 5 421
Phenylephrine Hydrochloride 10-mg/mL Injection Vol. 17 No. 5 422
Terbutaline Sulfate 1-mg/mL Injection Vol. 17 No. 5 423
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Vol. 17 No. 4 283
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Vol. 17 No. 4 307
Allopurinol Sodium 4-mg/mL Injection Vol. 17 No. 4 328
Amikacin Sulfate 250-mg/mL Injection Vol. 17 No. 4 329
Dacarbazine 200-mg/mL Injection Vol. 17 No. 4 330
Ketamine 50-mg/mL Injection Vol. 17 No. 4 331
Methohexital Sodium 500-mg/mL Injection Vol. 17 No. 4 332
Metoprolol Tartrate 1-mg/mL Injection Vol. 17 No. 4 333
Succinylcholine Chloride 50-mg/mL Injection Vol. 17 No. 4 335
Decontamination Technology: The Missing Element Vol. 17 No. 3 193
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Vol. 17 No. 3 238
Sterilization of Compounded Parenteral Products: Verification of Autoclaves Vol. 17 No. 2 94
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Vol. 17 No. 2 130
Basics of Compounding: Repackaging, Part 2 Vol. 17 No. 2 136
Adenosine 3-mg/mL Injection Vol. 17 No. 2 144
Alcohol Dehydrated Injection Vol. 17 No. 2 145
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Vol. 17 No. 2 147
Cyanocobalamin 1000-mcg/mL Injection Vol. 17 No. 2 148
Dexrazoxane 1-mg/mL Injection Vol. 17 No. 2 149
Meropenem 50-mg/mL Injection Vol. 17 No. 2 150
Paclitaxel 6-mg/mL Injection Vol. 17 No. 2 151
Thiotepa 15-mg/mL Injection Vol. 17 No. 2 152
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Vol. 17 No. 2 168
Basics of Compounding: Repackaging, Part 1 Vol. 17 No. 1 54
Desmopressin 4-mcg/mL Injection Vol. 17 No. 1 64
Dobutamine 10-mg/mL Injection Vol. 17 No. 1 65
Granisetron 1-mg/mL Injection Vol. 17 No. 1 66
Ibuprofen 10-mg/mL Injection Vol. 17 No. 1 67
Mepivacaine Hydrochloride 1% Injection Vol. 17 No. 1 68
Milrinone 0.2-mg/mL Injection Vol. 17 No. 1 69
Neostigmine Methylsulfate 0.5-mg/mL Injection Vol. 17 No. 1 70
Nicardipine Hydrochloride Injection Vol. 17 No. 1 71
Octreotide 50-mcg/mL Injection Vol. 17 No. 1 72
Testosterone Cypionate 100-mg/mL Injection Vol. 17 No. 1 73
Aminophylline 25-mg/mL Injection Vol. 16 No. 6 500
Ammonium Chloride 5-mEq/mL Injection Vol. 16 No. 6 501
Azathioprine 10-mg/mL Injection Vol. 16 No. 6 502
Copper 0.4-mg/mL Injection Vol. 16 No. 6 503
Dipyridamole 5-mg/mL Injection Vol. 16 No. 6 504
Dopamine Hydrochloride 80-mg/mL Injection Vol. 16 No. 6 505
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Vol. 16 No. 6 506
Papaverine Hydrochloride 30-mg/mL Injection Vol. 16 No. 6 507
Valproate Sodium 100-mg/mL Injection Vol. 16 No. 6 508
Vercuronium Bromide 1-mg/mL Injection Vol. 16 No. 6 509
Metronidazole 5-mg/mL Injection Vol. 16 No. 5 425
Doxapram Hydrochloride 20-mg/mL injection Vol. 16 No. 5 418
Enalaprilat 1.25-mg/mL Injection Vol. 16 No. 5 419
Esmolol Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 420
Fluconazole 2-mg/mL Injection Vol. 16 No. 5 421
Haloperidol 50-mg/mL in Oil Injection Vol. 16 No. 5 422
Meperidine Hydrochloride 50-mg/mL Injection Vol. 16 No. 5 423
Methocarbamol 100-mg/mL Injection Vol. 16 No. 5 424
Nalbuphine Hydrochloride 10-mg/mL Injection Vol. 16 No. 5 426
Oxymorphone Hydrochloride 1-mg/mL Injection Vol. 16 No. 5 427
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Vol. 16 No. 3 190
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Vol. 16 No. 1 86
Misinterpretation of United States Pharmacopeia Chapter <797> Vol. 16 No. 1 6
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Vol. 15 No. 5 390
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Vol. 15 No. 3 224
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Vol. 15 No. 2 133
PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Vol. 15 No. 1 4
A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Vol. 15 No. 1 20
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Vol. 15 No. 1 49
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Vol. 14 No. 6 493
Home Infusion: Overcoming the Barriers to Entry Vol. 14 No. 6 450
Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Vol. 14 No. 5 370
Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Vol. 14 No. 5 407
PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Vol. 14 No. 5 440
PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Vol. 14 No. 4 268
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Vol. 14 No. 4 270
Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Vol. 14 No. 4 317
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Vol. 14 No. 4 328
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Vol. 14 No. 3 232
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Vol. 14 No. 2 142
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Vol. 14 No. 2 160
Ophthalmic Toning-Lubricating Drops Vol. 14 No. 1 70
An Academic Practice Partnership: An Innovative Course in Advanced Compounding Vol. 14 No. 1 48
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Vol. 14 No. 1 60
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Vol. 13 No. 6 506
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Vol. 13 No. 6 540
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Vol. 13 No. 6 546
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Vol. 13 No. 6 564
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Vol. 13 No. 5 420
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Vol. 13 No. 4 290
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Vol. 13 No. 4 322
PostScription: Compounding Pharmacy in Puerto Rico Vol. 13 No. 4 350
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Vol. 13 No. 4 300
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Vol. 13 No. 3 234
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> Vol. 13 No. 2 94
Tips for Cleanroom Construction and Renovation Vol. 13 No. 2 100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Vol. 13 No. 2 106
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Vol. 13 No. 2 146
Acidified Sodium Hypochlorite for Antisepsis and Disinfection Vol. 13 No. 2 152
Quality Control Analytical Methods: Testing of Electrolytes Solutions Vol. 13 No. 1 53
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Vol. 13 No. 1 56
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Vol. 12 No. 5 440
Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Vol. 12 No. 6 524
Glycerin, Sterile Vol. 12 No. 6 542
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Vol. 12 No. 6 530
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Vol. 12 No. 4 344
Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Vol. 12 No. 4 321
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Vol. 12 No. 3 252
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Vol. 12 No. 3 216
Dilution and Compounding of Ziconotide for Intrathecal Administration Vol. 12 No. 3 200
Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Vol. 12 No. 2 130
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Vol. 12 No. 2 136
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Vol. 12 No. 1 54
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Vol. 11 No. 6 450
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Vol. 11 No. 6 492
Calculations: High-Technology Compounding and Investigational Dispensing Vol. 11 No. 6 500
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Vol. 11 No. 6 502
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Vol. 11 No. 5 400
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Vol. 11 No. 5 404
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 328
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 11 No. 4 302
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Vol. 11 No. 4 314
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 335
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Vol. 11 No. 3 230
Quality Control Analytical Methods: The Quality of Sterility Testing Vol. 11 No. 1 52
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Vol. 10 No. 6 428
Quality-Control Analytical Methods: Sterility Failure Investigations Vol. 10 No. 5 372
Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Vol. 10 No. 4 277
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Vol. 10 No. 4 281
Aseptic Compounding in New Zealand and the Use of Still Air Boxes Vol. 10 No. 4 293
Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Vol. 10 No. 4 253
Putting the Science Back into the "Art and Science" of Compounding Vol. 10 No. 4 263
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Vol. 10 No. 3 165
Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Vol. 10 No. 3 172
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Vol. 10 No. 3 202
Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Vol. 10 No. 3 218
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Vol. 10 No. 3 208
Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Vol. 10 No. 2 113
Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Vol. 10 No. 1 36
How'd They Do That? Vol. 10 No. 1 46
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Vol. 10 No. 1 69
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 390
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Vol. 9 No. 5 395
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 9 No. 2 127
PostScription: Experts Everywhere Vol. 9 No. 2 167
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Vol. 9 No. 1 11
Using ACDs in the Practice of Pharmacy Vol. 9 No. 1 15
USP Chapter <797> and Preparing for a JCAHO Survey Vol. 9 No. 1 23
Questions and Answers: USP Chapter <797> and JCAHO Compliance Vol. 9 No. 1 29
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Vol. 9 No. 1 33
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Vol. 9 No. 1 47
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Vol. 9 No. 1 53
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Vol. 8 No. 6 466
Calculations Vol. 8 No. 6 468
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Vol. 8 No. 6 479
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Vol. 8 No. 5 393
PreScription - Categories of Pharmaceutial Compounding Vol. 8 No. 4 242
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Clonidine HCl 1.5-mg/mL Injection Vol. 8 No. 3 216
Fluorouracil 1% Ophthalmic Solution Vol. 8 No. 3 217
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Vol. 8 No. 3 220
Testosterone Propionate 100-mg/mL in Oil Injection Vol. 8 No. 3 222
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Vol. 8 No. 2 89
Netilmicin 0.455% Ophthalmic Solution Vol. 8 No. 2 138
Pyridoxine HCl 100-mg/mL Injection, Preservative Free Vol. 8 No. 2 139
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Glycerin 50% Injection Vol. 8 No. 1 54
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Phenol 5%-in-Oil Injection Vol. 8 No. 1 57
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Containment of Hazardous Particulates in the Compounding Pharmacy Vol. 7 No. 4 281
Stability of Amikacin Sulfate in AutoDose Infusion System Bags Vol. 7 No. 3 230
Autoclaves for the Sterilization of Compounded Parenteral Products Vol. 7 No. 2 114
Technology Spotlight: Barrier Isolators Vol. 7 No. 1 42
Comparison of Endotoxin Testing Methods for Pharmaceutical Products Vol. 6 No. 6 408
Book Review: Sterile Compounding Vol. 6 No. 6 414
Sterile Compounding of Respiratory Inhalation Solutions Vol. 6 No. 6 415
Benzalkonium Chloride 1:750 Solution for Cold Disinfection Vol. 6 No. 6 448
Furosemide 10-mg/mL Injection Vol. 6 No. 6 453
Phenobarbital Sodium 130-mg/mL Injection Vol. 6 No. 6 457
Cleaning and Disinfection Vol. 6 No. 6 466
Sterilization of Talc for Use in Pleurodesis Vol. 6 No. 2 140
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Vol. 6 No. 1 55
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Vol. 5 No. 6 422
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Vol. 5 No. 6 455
New Perspectives on Vancomycin Use in Home Care, Part 1 Vol. 5 No. 6 465
Cross-contamination in Porcelain Mortars Vol. 5 No. 6 476
Quality Assurance for Sterile Products Vol. 5 No. 4 246
Sterile Compounding with Barrier-Isolation Technology Vol. 5 No. 4 254
Bacterial Endotoxins and Pyrogens Vol. 5 No. 4 259
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Vol. 5 No. 4 265
Sterile Compounding: Excerpts from the Reviews of Current Published Literature Vol. 5 No. 4 278
Analytical Testing Facilities and Products Vol. 5 No. 4 284
Maintenance of the Cleanroom Vol. 5 No. 4 313
Sterile-Product Preparations: Mix or Buy? Vol. 5 No. 1 59
Short Communication: Compounding for Implantable Pumps Vol. 4 No. 4 280
Dry Heat Sterilization of Parenteral Oil Vehicles Vol. 4 No. 3 223
Compounding Intrathecal Medications Vol. 4 No. 1 24
Standard Operating Procedure: Quality Assessment for Injectable Solutions Vol. 3 No. 5 406
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Vol. 3 No. 4 253
Sterilization and Depyrogenation Principles and Methods Vol. 3 No. 4 263
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Vol. 3 No. 4 270
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Vol. 3 No. 1 64
Testing for Bacterial Endotoxins Vol. 2 No. 5 379
Ophthalmic Compounding: Techniques for Achieving Sterility Vol. 2 No. 3 189
Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Vol. 2 No. 3 192
An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Vol. 2 No. 3 214
General Aseptic Procedures Used at a Laminar Airflow Workbench Vol. 2 No. 3 242